Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Akari Therapeutics ADR (AKTX)

1.33   -0.04 (-2.92%) 01-26 00:00
Open: 1.38 Pre. Close: 1.37
High: 1.4099 Low: 1.31
Volume: 83,663 Market Cap: 69M
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.413 - 1.421 1.421 - 1.428
Low: 1.291 - 1.301 1.301 - 1.309
Close: 1.316 - 1.332 1.332 - 1.344

Technical analysis

as of: 2022-01-25 4:22:03 PM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 1.76     One year: 1.92
Support: Support1: 1.29    Support2: 1.07
Resistance: Resistance1: 1.51    Resistance2: 1.64
Pivot: 1.44
Moving Average: MA(5): 1.40     MA(20): 1.44
MA(100): 1.61     MA(250): 1.95
MACD: MACD(12,26): -0.04     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 28.23     %D(3): 39.03
RSI: RSI(14): 32.45
52-week: High: 4.21  Low: 1.29  Change(%): -47.4
Average Vol(K): 3-Month: 105  10-Days: 86

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AKTX has closed below the lower band by 20.8%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 23.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 30 Dec 2021
European ADRs Trading Slightly Higher Thursday - InvestorsObserver

Thu, 30 Dec 2021
Healthcare Stocks Making Moves Thursday: KPRX, BLFE, MTEM, RDHL, BFRIW, BFRI, AKTX, TOI - InvestorsObserver

Tue, 23 Feb 2021
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts - Yahoo Finance

Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 48
Shares Float (M) 29
% Held by Insiders 21.76
% Held by Institutions 14.75
Shares Short (K) 145
Shares Short P. Month (K) 30

Stock Financials

EPS -0.491
EPS Est This Year -2.360
EPS Est Next Year -3.110
Book Value (p.s.) 0.240
Profit Margin
Operating Margin
Return on Assets (ttm) -80.2
Return on Equity (ttm) -227.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.383
Qtrly Earnings Growth
Operating Cash Flow (M) -18
Levered Free Cash Flow (M) -17

Stock Valuations

PE Ratio -2.71
PEG Ratio
Price to Book value 5.54
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.